The Immunogenicity and Safety of 2012-2013 Trivalent Seasonal Influenza Vaccine

Summary

The purpose of this study is to evaluate the immunogenicity and safety of 2012-2013 trivalent seasonal influenza vaccine in 60 healthy infants aged 6-35 months old, 60 healthy adults aged 18-60 years old, and 60 healthy older people aged \> 60 years.

Timeline

Start

2012-11

Primary completion

2013-04

Completion

2013-05

Drugs

Indications